n-nitrosobutylurea has been researched along with Lymphoma, B-Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akatsuka, Y; Kuzushima, K; Matsudaira, Y; Nishida, K; Obata, Y; Okanami, Y; Ozeki, S; Taguchi, O; Takahashi, T; Tsujimura, K | 1 |
1 other study(ies) available for n-nitrosobutylurea and Lymphoma, B-Cell
| Article | Year |
|---|---|
Immunity against mouse thymus-leukemia antigen (TL) protects against development of lymphomas induced by a chemical carcinogen, N-butyl-N-nitrosourea.
Topics: Animals; Antigens, Neoplasm; Carcinogens; Graft Rejection; H-2 Antigens; Lymphoma; Lymphoma, B-Cell; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Nitrosourea Compounds; Skin Transplantation; Species Specificity | 2004 |